Atticus Wealth Management LLC Sells 109 Shares of Elevance Health, Inc. (NYSE:ELV)

Atticus Wealth Management LLC lowered its stake in shares of Elevance Health, Inc. (NYSE:ELV) by 31.2% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 240 shares of the company’s stock after selling 109 shares during the quarter. Atticus Wealth Management LLC’s holdings in Elevance Health were worth $88,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors also recently bought and sold shares of the stock. Raelipskie Partnership bought a new stake in Elevance Health during the third quarter worth about $26,000. PSI Advisors LLC purchased a new stake in shares of Elevance Health in the 3rd quarter worth approximately $27,000. Eastern Bank bought a new position in Elevance Health during the 3rd quarter valued at approximately $31,000. Dunhill Financial LLC raised its stake in Elevance Health by 57.8% during the third quarter. Dunhill Financial LLC now owns 71 shares of the company’s stock valued at $37,000 after buying an additional 26 shares during the last quarter. Finally, Peterson Financial Group Inc. bought a new stake in Elevance Health in the third quarter worth $44,000. 89.24% of the stock is owned by institutional investors.

Elevance Health Trading Up 0.0 %

ELV opened at $401.43 on Monday. Elevance Health, Inc. has a one year low of $362.21 and a one year high of $567.26. The company has a debt-to-equity ratio of 0.56, a quick ratio of 1.50 and a current ratio of 1.50. The stock has a market cap of $93.10 billion, a price-to-earnings ratio of 14.63, a P/E/G ratio of 1.11 and a beta of 0.84. The stock’s 50 day moving average price is $386.21 and its 200-day moving average price is $461.87.

Elevance Health (NYSE:ELV) last posted its quarterly earnings results on Thursday, January 23rd. The company reported $3.84 EPS for the quarter, topping analysts’ consensus estimates of $3.80 by $0.04. Elevance Health had a net margin of 3.68% and a return on equity of 19.56%. On average, equities analysts forecast that Elevance Health, Inc. will post 32.95 EPS for the current year.

Elevance Health Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Tuesday, March 25th. Stockholders of record on Monday, March 10th will be given a dividend of $1.71 per share. This is an increase from Elevance Health’s previous quarterly dividend of $1.63. The ex-dividend date of this dividend is Monday, March 10th. This represents a $6.84 dividend on an annualized basis and a dividend yield of 1.70%. Elevance Health’s dividend payout ratio is presently 23.77%.

Analysts Set New Price Targets

Several equities analysts have recently weighed in on ELV shares. TD Cowen reduced their price target on Elevance Health from $589.00 to $484.00 and set a “buy” rating for the company in a report on Monday, October 21st. Raymond James set a $485.00 target price on shares of Elevance Health in a research note on Friday, October 18th. Stephens downgraded shares of Elevance Health from an “overweight” rating to an “equal weight” rating and reduced their price target for the company from $520.00 to $440.00 in a research report on Wednesday, January 22nd. Wells Fargo & Company lowered their price objective on Elevance Health from $593.00 to $495.00 and set an “overweight” rating on the stock in a research report on Monday, November 4th. Finally, UBS Group reduced their target price on Elevance Health from $605.00 to $555.00 and set a “buy” rating for the company in a report on Friday, October 18th. Three research analysts have rated the stock with a hold rating, thirteen have issued a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $525.60.

Elevance Health Company Profile

Elevance Health, Inc, together with its subsidiaries, operates as a health benefits company in the United States. The company operates through four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to program members; health products; an array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, life, disability, and supplemental health insurance benefits.